HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Lin Selected Research

Biomarkers (Surrogate Marker)

2/2024Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study.
4/2023Significantly elevated serum human epididymis protein-4 in chronic kidney disease patients without ovarian cancer: A large-scale retrospective study.
1/2023Efficacy of repetitive transcranial magnetic stimulation and agomelatine on sleep quality and biomarkers of adult patients with mild to moderate depressive disorder.
1/2023Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.
12/2022Prognostic value of MSI2 expression in human malignancies: A PRISMA-compliant meta-analysis.
11/2022Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
1/2022Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma.
5/2021Plasma interleukin-6 is a potential predictive biomarker for postoperative delirium among acute type a aortic dissection patients treated with open surgical repair.
2/2021Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.
1/2021The Potential of circRNA as a Novel Diagnostic Biomarker in Cervical Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Lin Research Topics

Disease

188Neoplasms (Cancer)
01/2024 - 10/2002
44Lung Neoplasms (Lung Cancer)
10/2023 - 01/2006
38Infections
08/2023 - 01/2008
35Carcinogenesis
01/2019 - 10/2004
34Breast Neoplasms (Breast Cancer)
01/2022 - 12/2011
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 10/2007
24Inflammation (Inflammations)
04/2024 - 09/2003
23Prostatic Neoplasms (Prostate Cancer)
04/2023 - 03/2004
22Hepatocellular Carcinoma (Hepatoma)
12/2023 - 11/2008
17Neoplasm Metastasis (Metastasis)
10/2023 - 01/2008
13Fibrosis (Cirrhosis)
01/2024 - 08/2005
12Hypertension (High Blood Pressure)
09/2023 - 06/2006
10COVID-19
02/2024 - 01/2020
10Obesity
09/2023 - 09/2008
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2003
9Glioma (Gliomas)
10/2021 - 10/2017
9Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2003
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2005
9Rheumatoid Arthritis
01/2020 - 01/2017
8Stomach Neoplasms (Stomach Cancer)
11/2023 - 12/2012
8Necrosis
06/2023 - 06/2003
8Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 12/2008
7Chronic Hepatitis B
12/2022 - 01/2013
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2013
7Syphilis
12/2021 - 01/2018
7Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 12/2011
6Carcinoma (Carcinomatosis)
01/2023 - 08/2005
6Body Weight (Weight, Body)
05/2022 - 12/2006
6Glioblastoma (Glioblastoma Multiforme)
02/2022 - 10/2017
5Ovarian Neoplasms (Ovarian Cancer)
04/2023 - 12/2010
5Alzheimer Disease (Alzheimer's Disease)
01/2023 - 12/2014
5Virus Diseases (Viral Diseases)
01/2022 - 09/2014
4Aortic Dissection
01/2024 - 09/2019
4Neutropenia
10/2023 - 05/2017
4Hypoxia (Hypoxemia)
10/2023 - 06/2008

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2003
33Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2005
23CytokinesIBA
01/2022 - 11/2008
20DNA (Deoxyribonucleic Acid)IBA
12/2022 - 10/2002
18Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2003
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2020 - 01/2006
15Messenger RNA (mRNA)IBA
12/2023 - 12/2006
15MicroRNAs (MicroRNA)IBA
01/2022 - 12/2012
14NF-kappa B (NF-kB)IBA
01/2011 - 06/2003
13Glucose (Dextrose)FDA LinkGeneric
01/2024 - 12/2006
13Phosphotransferases (Kinase)IBA
01/2021 - 06/2003
12TeaIBA
04/2024 - 01/2002
12CarcinogensIBA
01/2017 - 10/2002
11sarilumabIBA
10/2023 - 01/2017
10Insulin (Novolin)FDA Link
01/2024 - 04/2010
9Interleukin-6 (Interleukin 6)IBA
10/2023 - 01/2012
9Doxorubicin (Adriamycin)FDA LinkGeneric
10/2023 - 12/2002
9Small Interfering RNA (siRNA)IBA
08/2022 - 11/2006
9LipidsIBA
02/2021 - 12/2006
9LigandsIBA
06/2019 - 10/2007
9AndrogensIBA
10/2018 - 02/2005
8SmokeIBA
01/2020 - 01/2011
7Transcription Factors (Transcription Factor)IBA
04/2023 - 04/2008
7AntigensIBA
01/2023 - 01/2008
7Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2022 - 06/2009
7GemcitabineFDA Link
01/2021 - 10/2007
7Caffeine (No Doz)FDA LinkGeneric
01/2013 - 01/2002
6Peptides (Polypeptides)IBA
10/2023 - 10/2017
6Therapeutic UsesIBA
01/2023 - 10/2002
6AntioxidantsIBA
05/2022 - 11/2008
6Estrogen ReceptorsIBA
01/2022 - 11/2012
6Long Noncoding RNAIBA
10/2021 - 06/2014
6Mitogen-Activated Protein KinasesIBA
01/2019 - 06/2003
6LuteolinIBA
07/2018 - 05/2007
6Tocopherols (Tocopherol)IBA
01/2018 - 03/2011
6Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 08/2003
6Caspase 3 (Caspase-3)IBA
01/2015 - 01/2002
6Atorvastatin (Lipitor)FDA Link
06/2014 - 09/2007
6Celecoxib (Celebrex)FDA Link
06/2014 - 10/2004
6Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014 - 07/2004
6FlavonoidsIBA
08/2012 - 05/2007
5Prostate-Specific Antigen (Semenogelase)IBA
01/2023 - 02/2005
5AdipokinesIBA
01/2022 - 06/2012
5AntibodiesIBA
12/2021 - 01/2008
5Circular RNAIBA
08/2021 - 01/2018
5Metformin (Glucophage)FDA LinkGeneric
01/2020 - 08/2015
5Antirheumatic Agents (DMARD)IBA
01/2020 - 01/2017
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 05/2008
5Matrix Metalloproteinases (MMPs)IBA
01/2018 - 08/2003
5Mucin-1 (CA 15-3 Antigen)IBA
10/2017 - 01/2012
5wogoninIBA
06/2017 - 04/2011
5RamucirumabIBA
02/2017 - 06/2015
4PolyphenolsIBA
04/2024 - 05/2007
4Protein Kinases (Protein Kinase)IBA
02/2024 - 05/2004
4Phenobarbital (Luminal)FDA Link
01/2024 - 12/2015
4Methotrexate (Mexate)FDA LinkGeneric
11/2023 - 05/2017
4Vincristine (Oncovin)FDA LinkGeneric
10/2023 - 12/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 01/2021

Therapy/Procedure

83Therapeutics
02/2024 - 05/2003
22Drug Therapy (Chemotherapy)
11/2023 - 10/2002
12Radiotherapy
04/2023 - 11/2003
6Injections
06/2014 - 03/2004
5Immunotherapy
05/2024 - 12/2019
5Conservative Treatment
01/2018 - 07/2008
4Stents
01/2024 - 01/2009